Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.12B |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$502M |
| 3 |
Microsoft
MSFT
|
+$494M |
| 4 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$376M |
| 5 |
Invesco WilderHill Clean Energy ETF
PBW
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.04B |
| 2 |
Tesla
TSLA
|
+$835M |
| 3 |
CD
Chindata Group Holdings Limited American Depositary Shares
CD
|
+$447M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$422M |
| 5 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$395M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.14% |
| 2 | Consumer Discretionary | 6.15% |
| 3 | Financials | 6.01% |
| 4 | Healthcare | 4.67% |
| 5 | Communication Services | 4.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLXN
4751
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $256K | ﹤0.01% |
22,187
+17,571
| +381% | +$204K |
|
|
BRKL
4752
DELISTED
Brookline Bancorp
BRKL
| $254K | ﹤0.01% |
21,131
+11,553
| +121% | +$125K |
|
|
JNPR
4753
CALL
DELISTED
Juniper Networks
JNPR
| $254K | ﹤0.01% |
11,300
-15,600
| -58% | -$340K |
|
4754
CALL
Alcon
ALC
$33.6B
| $253K | ﹤0.01% |
3,800
| – | – |
|
|
ETG
4755
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.8B
| $253K | ﹤0.01% |
13,850
| – | – |
|
4756
Nelnet
NNI
$4.88B
| $253K | ﹤0.01% |
3,553
+2,365
| +199% | +$160K |
|
|
RWT
4757
Redwood Trust
RWT
$574M
| $253K | ﹤0.01% |
28,835
+1,561
| +6% | +$13.4K |
|
4758
CALL
Sunstone Hotel Investors
SHO
$2.19B
| $253K | ﹤0.01% |
+22,300
| New | +$213K |
|
|
AMJ
4759
CALL
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $253K | ﹤0.01% |
18,200
-7,500
| -29% | -$97.6K |
|
|
BBT
4760
Beacon Financial Corp
BBT
$2.66B
| $252K | ﹤0.01% |
14,723
+3,235
| +28% | +$48.3K |
|
4761
CorVel
CRVL
$3.06B
| $252K | ﹤0.01% |
7,119
+4,896
| +220% | +$152K |
|
4762
StoneX
SNEX
$9.26B
| $252K | ﹤0.01% |
22,027
+15,410
| +233% | +$174K |
|
|
CNST
4763
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $252K | ﹤0.01% |
8,760
+3,220
| +58% | +$81.1K |
|
4764
American Well
AMWL
$180M
| $251K | ﹤0.01% |
+495
| New | +$287K |
|
4765
PUT
Eastman Chemical
EMN
$8B
| $251K | ﹤0.01% |
2,500
-16,300
| -87% | -$1.51M |
|
4766
Ribbon Communications
RBBN
$377M
| $251K | ﹤0.01% |
38,259
+8,725
| +30% | +$46.1K |
|
|
BFT
4767
DELISTED
Foley Trasimene Acquisition Corp. II
BFT
| $251K | ﹤0.01% |
+16,657
| New | +$190K |
|
|
FTSI
4768
DELISTED
FTS International, Inc. Common Stock
FTSI
| $251K | ﹤0.01% |
+13,077
| New | +$129K |
|
4769
OceanFirst Financial
OCFC
$1.68B
| $250K | ﹤0.01% |
13,414
+1,607
| +14% | +$26.3K |
|
4770
Oceaneering
OII
$4.86B
| $250K | ﹤0.01% |
31,388
-17,893
| -36% | -$104K |
|
4771
Omeros
OMER
$857M
| $250K | ﹤0.01% |
17,493
+4,656
| +36% | +$56.9K |
|
4772
E.W. Scripps
SSP
$257M
| $250K | ﹤0.01% |
16,326
+10,285
| +170% | +$127K |
|
4773
Simulations Plus
SLP
$369M
| $249K | ﹤0.01% |
3,463
+818
| +31% | +$54.2K |
|
|
PRVB
4774
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $249K | ﹤0.01% |
14,716
+6,288
| +75% | +$94.3K |
|
4775
Calumet Specialty Products
CLMT
$3.85B
| $248K | ﹤0.01% |
79,204
+25,709
| +48% | +$89.6K |
|
Similar funds
Citigroup's Q4 2020 Portfolio in Review
As of Q4 2020, Citigroup held 7,861 positions worth $169B, up 11% from $153B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup withdrew a net $7.76B in Q4 2020, closing 461 positions and reducing 2,432 holdings. Its most notable exit was TD Ameritrade Holding Corp, an estimated $395M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8.7% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Citigroup opened a new position in State Street US Sector Rotation ETF worth $36.3M.
- Citigroup's largest Q4 2020 buy was State Street US Sector Rotation ETF: 900,000 shares worth $36.3M.
- Citigroup added most to iShares Russell 2000 ETF in Q4 2020, an estimated $1.12B increase.
- Citigroup's biggest Q4 2020 reduction was Invesco QQQ Trust, cutting an estimated $1.04B.
- Citigroup fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $395M.
- Citigroup's ten largest holdings make up 22% of its $169B portfolio in Q4 2020.
- Citigroup opened 370 new positions and closed 461 in Q4 2020.
- Citigroup's portfolio value rose 11% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q4 2020, filed 11 Feb 2021.